Kraig Biocraft Laboratories Expands R D Capacity for Spider Silk . . . Kraig Biocraft Laboratories, a leader in spider silk technology, has significantly expanded its research and development capacity to keep pace with rapid progress in its Project Atlas advanced materials initiative The company has onboarded new scientific personnel, deployed new advanced equipment, and roughly tripled its screening throughput, allowing the R D team to quickly identify and
Kraig Biocraft Laboratories - Wikipedia Kraig Biocraft Laboratories, Inc is an American biotechnology company headquartered in Ann Arbor, Michigan It develops and manufactures recombinant spider silks and other high-performance polymers using spider silk gene sequences [1]
Kraig Biocraft triples screening for spider silk R D | KBLB Stock News Kraig Biocraft Laboratories (OTCQB: KBLB) expanded its R D capacity for Project Atlas on March 23, 2026, roughly tripling screening throughput and adding staff and advanced equipment The upgrades automate testing workflows, strengthen analytical assays, increase parallel transgenic line evaluation, and aim to shorten development timelines and accelerate selection of production candidates
Kraig Biocraft Laboratories Increases R D Capacity, as Project Atlas . . . Kraig Labs implemented these upgrades in direct response to the rapid technical progress made under Project Atlas Atlas is the Company’s next-generation recombinant spider silk program focused on creating advanced biomaterials with potential industrial and defense applications
News - Kraig Biocraft Laboratories By automating portions of the testing workflow, Kraig Labs can now rapidly process and evaluate significantly more samples, quickly identifying new, exciting transgenics In addition to the increased screening capacity, Kraig Labs also strengthened its analytical testing capabilities